Venom Sleeper Issues with Upside Potential, article illustration

The real "sleepers" in the Venom family aren't the marquee issues like Amazing Spider-Man #300 (median €529, 101 eBay listings, June 2026), but issues with genuine historical weight whose values stay low: ASM #315 (median €45, 2nd Venom), #317 (median €41, McFarlane's last Venom) and #362-363 (2nd and 3rd Carnage, medians €20 and €17). Here are the verified facts and real values: no invented projections.

For collectors, a "sleeper" is an issue with documented narrative importance that still trades below the headline issues: usually because the market concentrates demand on the first appearance. With Venom, the first full appearance (#300) absorbs almost all the attention, leaving several neighbouring issues undervalued.

This guide sticks to verifiable data: attested historical significance and real-time eBay values via our estimator. Potential is described qualitatively: never as an invented future price.

Why these issues are sleepers

Two mechanics explain the value gap, with nothing invented:

Issues mentioned : Venom Sleeper Issues with Upside Potential

McFarlane's "Return of Venom" arc (1989)

After #300, David Michelinie and Todd McFarlane delivered a three-part arc (ASM #315-317, May-July 1989) that locked in Venom's iconic design and chaotic tone. Verified significance: #315 = 2nd Venom appearance , #316 = first full Venom cover , #317 = final Venom drawn by McFarlane (sources: Marvel Fandom, keenlinks).

Yet the market only really values the cover (#316). The other two stay affordable:

IssueHistorical significanceeBay median (June 2026)
ASM #3152nd Venom, opens the McFarlane arc€45 · 99 listings
ASM #316First full Venom cover€208 · 100 listings
ASM #317McFarlane's last Venom€41 · 100 listings

The gap is telling: #316 is worth nearly five times #315 and #317, even though all three form a single arc. For anyone wanting a McFarlane page from a key moment in the character's run, #315 and #317 are the clearest sleeper candidates.

The 1992 "Carnage trio"

Carnage first appears in ASM #361 (1992), then #362 and #363 complete his first three consecutive appearances: #362 featuring the unlikely Spider-Man + Venom team-up against Carnage (source: Marvel Fandom). Here too, value concentrates on #361:

#362 and #363 are essential to complete the first-appearance trio, yet sell for a fraction of #361. Their low listing volume (especially #363) reflects relative scarcity in circulation: a factor every sleeper hunter watches.

Beyond Amazing Spider-Man: check case by case

Some major sleepers aren't Amazing Spider-Man issues and are therefore not indexed by our eBay estimator (limited to that title):

For these titles, always check the value at purchase time against real sales: don't trust a price from memory.

How to approach a sleeper, concretely

A sleeper's potential isn't promised: it's prepared: well-identified issues, controlled condition, value tracked against real sales.

Own a Venom or Carnage comic? Get a free valuation with our tool based on real eBay sales to find its low, median and high value.

Frequently asked questions

An issue with documented narrative importance whose price stays below that of the headline issues, often because the market concentrates demand on the first appearance. Here, Amazing Spider-Man #300 draws almost all the attention.

ASM #315 (Venom's 2nd appearance) and #317 (Venom's last appearance drawn by McFarlane), while #316 (first full cover) concentrates the pricing. The three form a single arc by David Michelinie and Todd McFarlane (May-July 1989).

ASM #362 and #363, after #361, which introduces Carnage in 1992. #362 sees the improbable alliance of Spider-Man and Venom against Carnage.

Yes, for example Venom: Lethal Protector #1 (1993), Eddie Brock's first solo series, a 6-issue miniseries that confirms the anti-hero turn. It is very common: examine condition before buying.

Favor documented importance, check condition, since a certified high-grade copy sits far above the displayed median, and track your target issues on real sales. A sleeper's potential is not promised, it is prepared.